Leaving No Hole Unclosed: Left Atrial Appendage Occlusion in Patients Having Closure of Patent Foramen Ovale or Atrial Septal Defect

2014 ◽  
Vol 27 (4) ◽  
pp. 414-422 ◽  
Author(s):  
SAMEER GAFOOR ◽  
JENNIFER FRANKE ◽  
PATRICK BOEHM ◽  
SIMON LAM ◽  
STEFAN BERTOG ◽  
...  
2020 ◽  
Vol 16 (2) ◽  
pp. e173-e180 ◽  
Author(s):  
Caroline Kleinecke ◽  
Monika Fuerholz ◽  
Eric Buffle ◽  
Stefano de Marchi ◽  
Steffen Schnupp ◽  
...  

2014 ◽  
Vol 30 (1) ◽  
pp. 87-95 ◽  
Author(s):  
Xavier Freixa ◽  
Dabit Arzamendi ◽  
Apostolos Tzikas ◽  
Stephane Noble ◽  
Arsene Basmadjian ◽  
...  

Author(s):  
Apostolos Tzikas ◽  
Konstantinos Papadopoulos ◽  
Dimitrios Konstantinou ◽  
George Ntaios ◽  
Chourmouzios Arampatzis

2014 ◽  
Vol 84 (7) ◽  
pp. 1190-1196 ◽  
Author(s):  
Dezsoe Koermendy ◽  
Fabian Nietlispach ◽  
Samera Shakir ◽  
Steffen Gloekler ◽  
Peter Wenaweser ◽  
...  

2011 ◽  
Vol 6 (1) ◽  
pp. 67
Author(s):  
Antonio L Bartorelli ◽  
Claudio Tondo ◽  
◽  

Innovative percutaneous procedures for stroke prevention have emerged in the last two decades. Transcatheter closure of the patent foramen ovale (PFO) is performed in patients who suffered a cryptogenic stroke or a transient ischaemic attach (TIA) in order to prevent recurrence of thromboembolic events. Percutaneous occlusion of the left atrial appendage (LAA) has been introduced to reduce stroke risk in patients with atrial fibrillation (AF). The role of PFO and LAA in the occurrence of cerebrovascular events and the interventional device-based therapies to occlude the PFO and LAA are discussed.


2021 ◽  
Vol 3 (3) ◽  
pp. 508-511
Author(s):  
Omar Kousa ◽  
Toufik Mahfood-Haddad ◽  
Shantanu M. Patil ◽  
Himanshu Agarwal ◽  
Hussam Abuissa

Sign in / Sign up

Export Citation Format

Share Document